BioSpace News Archive

Catalyst Pharma Announces Proposed Public Offering of Common Stock

All of the shares in the offering are being sold by Catalyst.

November 28, 2017
·
3 min read
Policy

Dova Pharmaceuticals Announces FDA Acceptance of the Avatrombopag NDA With Priority Review

The Prescription Drug User Fee Act (PDUFA) goal date for an FDA decision is May 21, 2018.

November 28, 2017
·
4 min read
Prima BioMed Becomes Immutep

The Company is pleased to advise that the name Immutep Limited has been formally adopted after ASIC registration.

November 28, 2017
·
1 min read
Drug Development

Aptevo Therapeutics Announces Plans to Conduct Phase II Study of Otlertuzumab in Peripheral T-Cell Lymphoma

In addition, the company expects to file 2 Investigational New Drug (IND) applications in 2018 for 2 bispecific antibody candidates

November 28, 2017
·
8 min read
U.S. Patent Office Acknowledges Provisional Patent Application for Use of Specific Cannabis Strain to Enhance Opioid Analgesia Filed by Veritas’ Research Arm Cannevert

An acknowledgement letter from the USPTO was received recently which provided a filing number of US 62/558,021 for this application.

November 28, 2017
·
4 min read
Business

Optinose Reports Third Quarter 2017 Financial Results and Recent Operating Highlights

Research and development expenses for the three-month period ended September 30, 2017, were $6.6 million.

November 28, 2017
·
9 min read
Business

Telcare, a Division of BioTelemetry, Announces Collaboration With Onduo in Diabetes Management Program

Telcare will serve as the supplier of remote blood glucose systems and the resulting data for patients enrolled in Onduo’s groundbreaking diabetes management program.

November 28, 2017
·
3 min read
Business

OncoMed Announces Chairman, President and Chief Executive Officer Paul J. Hastings to Resume Chairman Responsibilities

Office of the President continues to perform the duties of President and CEO.

November 28, 2017
·
3 min read
Biotech Bay

Varian Medical Schedules Annual Stockholder Meeting in Palo Alto

Varian Medical Systems announced today that its Board of Directors has scheduled the 2018 Annual Meeting of Stockholders for February 8, 2018 with a record date of December 11, 2017.

November 28, 2017
·
1 min read
Biotech Bay

Veracyte Announces Publication of Data Confirming Analytical Validity of Envisia Genomic Classifier for Use in IPF Diagnosis

The findings add to the growing body of evidence, including previously reported clinical validity and clinical utility data, supporting the use of the Envisia classifier to enable diagnosis of IPF, without the need for invasive, risky and costly surgical procedures.

November 28, 2017
·
5 min read